Daiwa Securities Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Daiwa Securities Group’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-86	Closed	–	–	1416
2022 Q3	$0	Hold	86	–	–	﹤0.01%	1423
2022 Q2	$0	Hold	86	–	–	﹤0.01%	1457
2022 Q1	$0	Hold	86	–	–	﹤0.01%	1436
2021 Q4	$0	Hold	86	–	–	﹤0.01%	1470
2021 Q3	$0	Hold	86	–	–	﹤0.01%	1354
2021 Q2	$1K	Hold	86	–	–	﹤0.01%	1237
2021 Q1	$1K	Hold	86	–	–	﹤0.01%	1248
2020 Q4	$1K	Buy	+86	New	+$506	﹤0.01%	1230
2019 Q4	–	Sell	-173	Closed	-$1K	–	1256
2019 Q3	$1K	Hold	173	–	–	﹤0.01%	1165
2019 Q2	$1K	Hold	173	–	–	﹤0.01%	1191
2019 Q1	$1K	Hold	173	–	–	﹤0.01%	1171
2018 Q4	$1K	Hold	173	–	–	﹤0.01%	1135
2018 Q3	$2K	Hold	173	–	–	﹤0.01%	1134
2018 Q2	$2K	Hold	173	–	–	﹤0.01%	1151
2018 Q1	$2K	Buy	+173	New	+$2.58K	﹤0.01%	1136

Other funds holding PRTK

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Daiwa Securities Group's PRTK Position: Q4 2022 in Review

Daiwa Securities Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2022, closing a stake of 86 shares.

Daiwa Securities Group first reported a position in PRTK in Q1 2018 and held it in 15 quarters. The position peaked at $2K in Q3 2018. 76 funds tracked by Wall St. Rank hold PRTK as of Q4 2022.

Daiwa Securities Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Daiwa Securities Group sold 86 Paratek Pharmaceuticals, Inc. shares in Q4 2022.
Daiwa Securities Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2018 and held it in 15 quarters.
Daiwa Securities Group's Paratek Pharmaceuticals, Inc. position peaked at $2K in Q3 2018.
76 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.